Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer
ACS Nano · 01.10.2024 · 18 (39) · 26585-26599
DOI: 10.1021/acsnano.4c04322 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 17.09.2024. Verfasst von Jie Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, …. Hauptthemen laut MEDLINE: Ferroptosis, Triple Negative Breast Neoplasms, Glutathione, Receptors, Androgen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Shanghai Pudong New Area Health Commission.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Drug Research & Center of Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Pharmacy & Key Laboratory of Smart Drug Delivery (Ministry of Education), Fudan University, Shanghai 201203, China.
- Department of Breast Surgery, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai 201399, China.
- Shandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai 264117, Shandong, China.
ORCID-Profile: Zhiwen Zhang, Yaping Li
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Shanghai Pudong New Area Health Commission
Zitieren
APA
Li, J., Wu, Y., Li, Y., Zhu, H., Zhang, Z., & Li, Y. (2024). Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. ACS Nano, 18(39), 26585-26599. https://doi.org/10.1021/acsnano.4c04322
Vancouver
Li J, Wu Y, Li Y, Zhu H, Zhang Z, Li Y. Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer. ACS Nano. 2024;18(39):26585-26599. doi:10.1021/acsnano.4c04322
BibTeX
@article{Li2024,
author = {Li, Jie and Wu, Yao and Li, Yongping and Zhu, Hongbo and Zhang, Zhiwen and Li, Yaping},
title = {Glutathione-Disrupting Nanotherapeutics Potentiate Ferroptosis for Treating Luminal Androgen Receptor-Positive Triple-Negative Breast Cancer},
journal = {ACS Nano},
year = {2024},
volume = {18},
number = {39},
pages = {26585--26599},
doi = {10.1021/acsnano.4c04322}
}
EUVIMED